Bégin LR - Search Results

1

Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection.

Tanguay S, Bégin LR, Elhilali MM, Behlouli H, Karakiewicz PI, Aprikian AG. Tanguay S, et al. Among authors: begin lr. Urology. 2002 Feb;59(2):261-5. doi: 10.1016/s0090-4295(01)01497-2. Urology. 2002. PMID: 11834399

2

Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer.

Stephenson AJ, Aprikian AG, Souhami L, Behlouli H, Jacobson AI, Bégin LR, Tanguay S. Stephenson AJ, et al. Among authors: begin lr. Urology. 2002 May;59(5):652-6. doi: 10.1016/s0090-4295(02)01526-1. Urology. 2002. PMID: 11992834

3

Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 for prostate cancer detection in patients undergoing prostate biopsy.

Ismail A H, Pollak M, Behlouli H, Tanguay S, Begin LR, Aprikian AG. Ismail A H, et al. Among authors: begin lr. J Urol. 2002 Dec;168(6):2426-30. doi: 10.1016/S0022-5347(05)64160-2. J Urol. 2002. PMID: 12441932

4

Value of repeat ultrasonic prostatic biopsies following negative digitally directed biopsy.

Karakiewicz PI, Bazinet M, Meshref AW, Aprikian AG, Trudel C, Aronson S, Nachabé M, Péloquin F, Goyal MS, Bégin LR, Elhilali MM. Karakiewicz PI, et al. Among authors: begin lr. Can J Urol. 1997 Mar;4(1):289-292. Can J Urol. 1997. PMID: 12735801

5

Analysis of gland volume effect on the performance of PSA density in early detection of non-palpable, isoechoic prostate cancer.

Karakiewicz PI, Bazinet M, Aprikian AG, Trudel C, Aronson S, Péloquin F, Dessureault J, Nachabé M, Goyal MS, Bégin LR, Elhilali MM. Karakiewicz PI, et al. Among authors: begin lr. Can J Urol. 1996 Jun;3(2):212-220. Can J Urol. 1996. PMID: 12741973

6

Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.

Mahmud SM, Tanguay S, Bégin LR, Franco EL, Aprikian AG. Mahmud SM, et al. Among authors: begin lr. Eur J Cancer Prev. 2006 Apr;15(2):158-64. doi: 10.1097/01.cej.0000197451.02604.25. Eur J Cancer Prev. 2006. PMID: 16523013

7

Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort.

Barayan GA, Brimo F, Bégin LR, Hanley JA, Liu Z, Kassouf W, Aprikian AG, Tanguay S. Barayan GA, et al. Among authors: begin lr. BJU Int. 2014 Dec;114(6b):E99-E104. doi: 10.1111/bju.12754. Epub 2014 Aug 11. BJU Int. 2014. PMID: 24684511

8

Outcome of repeated prostatic biopsy during active surveillance: implications for focal therapy.

Barayan GA, Aprikian AG, Hanley J, Kassouf W, Brimo F, Bégin LR, Tanguay S. Barayan GA, et al. Among authors: begin lr. World J Urol. 2015 Sep;33(9):1275-80. doi: 10.1007/s00345-014-1433-z. Epub 2014 Nov 12. World J Urol. 2015. PMID: 25387875

9

Serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 do not correlate with Gleason score or quantity of prostate cancer in biopsy samples.

Ismail HA, Pollak M, Behlouli H, Tanguay S, Bégin LR, Aprikian AG. Ismail HA, et al. Among authors: begin lr. BJU Int. 2003 Nov;92(7):699-702. doi: 10.1046/j.1464-410x.2003.04084.x. BJU Int. 2003. PMID: 14616449 Clinical Trial.

10

Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.

Ozdal OL, Aprikian AG, Bégin LR, Behlouli H, Tanguay S. Ozdal OL, et al. Among authors: begin lr. BJU Int. 2004 May;93(7):970-4; discussion 974. doi: 10.1111/j.1464-410X.2003.04762.x. BJU Int. 2004. PMID: 15142145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters